tazarotene has been researched along with Local Neoplasm Recurrence in 5 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term use of corticosteroids or local use of tazarotene (TAZ) alone for the treatment of psoriasis cause safety issues and low compliance rates." | 9.34 | Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial. ( Chen, H; Gu, J; Li, M; Liu, X; Lou, D; Sun, J; Sun, Q; Wen, H; Yang, H; Zhang, J, 2020) |
| "Long-term use of corticosteroids or local use of tazarotene (TAZ) alone for the treatment of psoriasis cause safety issues and low compliance rates." | 5.34 | Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial. ( Chen, H; Gu, J; Li, M; Liu, X; Lou, D; Sun, J; Sun, Q; Wen, H; Yang, H; Zhang, J, 2020) |
| "We report a case of an 83-year-old female with locally metastatic melanoma treated with imiquimod and tazarotene." | 3.74 | Treatment of locally metastatic melanoma: a novel approach. ( Fenske, NA; Glass, LF; Prakash, AV; Shistik, G, 2007) |
| "Imiquimod cream has been used off-label as monotherapy in the treatment of LM and may be used in the neoadjuvant setting prior to staged excision as a strategy to reduce the size of the surgical margins required to confirm negative histologic margins." | 1.48 | Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision. ( Bowen, GM; Bowling, M; Donigan, JM; Goldgar, DE; Hadley, ML; Hyde, MA, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H | 1 |
| Sun, J | 1 |
| Yang, H | 2 |
| Sun, Q | 1 |
| Zhang, J | 1 |
| Gu, J | 1 |
| Wen, H | 1 |
| Li, M | 1 |
| Liu, X | 1 |
| Lou, D | 1 |
| Chambers, M | 1 |
| Swetter, SM | 1 |
| Baker, C | 1 |
| Saunders, E | 1 |
| Chapman, MS | 1 |
| Donigan, JM | 1 |
| Hyde, MA | 1 |
| Goldgar, DE | 1 |
| Hadley, ML | 1 |
| Bowling, M | 1 |
| Bowen, GM | 1 |
| Besner Morin, C | 1 |
| Roberge, D | 1 |
| Turchin, I | 1 |
| Petrogiannis-Haliotis, T | 1 |
| Popradi, G | 1 |
| Pehr, K | 1 |
| Shistik, G | 1 |
| Prakash, AV | 1 |
| Fenske, NA | 1 |
| Glass, LF | 1 |
2 trials available for tazarotene and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial.
Topics: Betamethasone; Clobetasol; Dermatologic Agents; Double-Blind Method; Humans; Neoplasm Recurrence, Lo | 2020 |
Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans | 2016 |
3 other studies available for tazarotene and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up | 2021 |
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Follow-Up | 2018 |
Treatment of locally metastatic melanoma: a novel approach.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy | 2007 |